The CareStart COVID-19 Antigen Covid-19 Test is a lateral flow immunochromatographic assay for the detection of extracted nucleocapsid protein antigens specific to SARS-CoV-2 in swab specimens directly collected from symptomatic individuals who are suspected of COVID-19 by their healthcare providers.
Due to the highly contagious nature and global health crisis, CareStart Covid-19 Antigen Home Test Kit in Colombia SARS-CoV-2 has been designated as a pandemic by the World Health Organization (WHO) and continues to have devastating impacts on healthcare systems and the world economy including the U.S. To effectively end the SARS-CoV-2 pandemic, systematic screening and detection of both clinical and asymptomatic COVID-19 cases is critical.
The CareStart Antigen test covers proteins of variants such as B.1.1.7 (Alpha), B.1.351 (Beta), B.1.1.248 (Gamma), B.1.617.1 (Kappa), B.1.617.2 (Delta), B.1.617.3, AY.1 (Delta plus), C.37 (Lambda).
As an intended point-of-care (POC) designated test with a 10 minute processing time, CareStart Covid-19 Antigen Home Test Kit in Colombia allows effective screening of COVID-19 infection on a large scale.
ateral flow assay
Rapid results in 10 minutes
Nasopharyngeal swab specimen collection
Intended at POC setting (i.e., in patient care settings) by medical professionals operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation
Detect SARS-CoV-2 nucleocapsid protein antigen
Identify acute infection in symptomatic patients with 88.4% sensitivity and 100% specificity
Designated as a CLIA waived tests